Literature DB >> 1320587

OHIO-1 beta-lactamase resistant to mechanism-based inactivators.

R A Bonomo1, C Currie-McCumber, D M Shlaes.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1320587     DOI: 10.1016/0378-1097(92)90545-y

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


× No keyword cloud information.
  15 in total

1.  What's New in beta-lactamases?

Authors:  Patricia A. Bradford
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

Review 2.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period.

Authors:  Elisenda Miró; Ferran Navarro; Beatriz Mirelis; Montserrat Sabaté; Alba Rivera; Pere Coll; Guillem Prats
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.

Authors:  S Lin; M Thomas; D M Shlaes; S D Rudin; J R Knox; V Anderson; R A Bonomo
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

Review 5.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

6.  Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamase.

Authors:  S Farzaneh; E B Chaibi; J Peduzzi; M Barthelemy; R Labia; J Blazquez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

7.  Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.

Authors:  P Giakkoupi; V Miriagou; M Gazouli; E Tzelepi; N J Legakis; L S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

8.  Molecular diversity and evolution of blaTEM genes encoding beta-lactamases resistant to clavulanic acid in clinical E. coli.

Authors:  M M Caniça; C Y Lu; R Krishnamoorthy; G C Paul
Journal:  J Mol Evol       Date:  1997-01       Impact factor: 2.395

9.  Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.

Authors:  E E Prinarakis; V Miriagou; E Tzelepi; M Gazouli; L S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

10.  Construction and characterization of an OHIO-1 beta-lactamase bearing Met69Ile and Gly238Ser mutations.

Authors:  R A Bonomo; J R Knox; S D Rudin; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.